Number of patients with complete clinical data | 60 |
Age (yr) | |
Range | 1.0-17.0 |
Median | 8.7 |
Sex | |
Male | 48 |
Female | 12 |
Counts at diagnosis | |
WBC (1,000/μL) | |
Median | 222.7 |
Range | 1.4-855.0 |
Peripheral blasts (1,000/μL) | |
Median | 181.4 |
Range | 0.04-698.4 |
HB (g/dL) | |
Median | 10.5 |
Range | 5.6-15.6 |
Platelets (1,000/μL) | |
Median | 82.8 |
Range | 14.0-258.0 |
Steroid response | |
Good* | 6 |
Poor-151 | 54 |
In remission on day 33 | |
Yes | 42 |
No | 6 |
NA | 12 |
Number of patients with complete clinical data | 60 |
Age (yr) | |
Range | 1.0-17.0 |
Median | 8.7 |
Sex | |
Male | 48 |
Female | 12 |
Counts at diagnosis | |
WBC (1,000/μL) | |
Median | 222.7 |
Range | 1.4-855.0 |
Peripheral blasts (1,000/μL) | |
Median | 181.4 |
Range | 0.04-698.4 |
HB (g/dL) | |
Median | 10.5 |
Range | 5.6-15.6 |
Platelets (1,000/μL) | |
Median | 82.8 |
Range | 14.0-258.0 |
Steroid response | |
Good* | 6 |
Poor-151 | 54 |
In remission on day 33 | |
Yes | 42 |
No | 6 |
NA | 12 |
*Peripheral blasts on day 8 of steroid induction <1000/μL.
Peripheral blasts on day 8 of steroid induction >1000/μL.
Abbreviation: NA, not applicable.